4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000038
CEO bought 111,000 shares at an average $0.01 ($1,256)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-06-05 | Purchase : show line 1 in the form | +20,000 | $0.01 | $224 | 24,211,097 | D |
| 2019-06-05 | Purchase : show line 2 in the form | +20,000 | $0.01 | $224 | 24,231,097 | D |
| 2019-06-05 | Purchase : show line 3 in the form | +20,000 | $0.01 | $224 | 24,251,097 | D |
| 2019-06-06 | Purchase : show line 4 in the form | +5,000 | $0.01 | $58 | 24,256,097 | D |
| 2019-06-06 | Purchase : show line 5 in the form | +15,000 | $0.01 | $168 | 24,271,097 | D |
| 2019-06-06 | Purchase : show line 6 in the form | +2,000 | $0.01 | $23 | 24,273,097 | D |
| 2019-06-06 | Purchase : show line 7 in the form | +2,000 | $0.01 | $23 | 24,275,097 | D |
| 2019-06-06 | Purchase : show line 8 in the form | +2,000 | $0.01 | $24 | 24,277,097 | D |
| Open-market purchases · 111,000 sh · avg $0.01 · $1,256 | ||||||
Loading xslF345X03/primary_doc.xml…